← Leaderboards
Joseph Zabner
University Of Iowa
$29,014,505
Attributed
$32,356,820
Total exposure
28
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$32,356,820 · 28
By mechanism
P01$13,298,519 · 13
R01$6,593,102 · 2
U01$5,326,883 · 1
P30$3,006,840 · 6
P50$2,225,561 · 1
T32$1,394,034 · 1
Top collaborators
- David A Stoltz5 shared
- Michael J. Welsh2 shared
Most similar at University Of Iowa
Same institution · by research overlap
- David A Stoltz$27,502,140
- Botond Banfi$6,604,080
- Mahmoud Abou Alaiwa$4,553,455
- Michael J. Welsh$31,109,771
- Harold M. Goff$347,026
Others in their field
Top investigators on “Family Suidae”
- David H Sachs · Columbia University Health Sciences$27,938,778
- David A Stoltz · University Of Iowa$23,917,771
- Jianyi Zhang · University Of Alabama At Birmingham$20,789,788
- Dafna Bar-Sagi · State University New York Stony Brook$19,477,294
- Devendra K. Agrawal · Creighton University$19,059,808
- Guillermo J. Tearney · Massachusetts General Hospital$18,973,444
Research focus
Family SuidaeCystic FibrosisAirway EpitheliumCellsResearch PersonnelEpitheliumLungPhenotypeCystic Fibrosis Transmembrane Conductance RegulatorIn Vitro ModelGene TherapyTissuesFunctional DisorderEvaluationUniversitiesBiological ModelsAnimalsPulmonary Cystic FibrosisInstitutionStudy ModelsResourcesGenerationsCell LineCell Culture Techniques
Grant awards (103)
Project 1$393,848
P01 · FY2025 · HL · contact PI
In Vitro Models and Cell Culture Core$178,795
P01 · FY2024 · HL · contact PI
Cells and Tissue Core-Core 5$156,510
P30 · FY2024 · DK · contact PI
In Vitro Models and Cell Culture Core$185,400
P01 · FY2023 · HL · contact PI
Cells and Tissue Core-Core 5$156,510
P30 · FY2023 · DK · contact PI
Project 3: Contribution of Small Airways to Cystic Fibrosis Lung Disease Pathogenesis$356,949
P01 · FY2022 · HL · contact PI
In Vitro Models and Cell Culture Core$185,400
P01 · FY2022 · HL · contact PI
Cells and Tissue Core-Core 5$156,510
P30 · FY2022 · DK · contact PI
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis$1,053,550
R01 · FY2021 · HL
Project 3: Contribution of Small Airways to Cystic Fibrosis Lung Disease Pathogenesis$356,949
P01 · FY2021 · HL · contact PI
In Vitro Models and Cell Culture Core$185,400
P01 · FY2021 · HL · contact PI
Cells and Tissue Core-Core 5$156,510
P30 · FY2021 · DK · contact PI
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis$1,054,599
R01 · FY2020 · HL
Multidisciplinary Lung Research Career Development Program$358,242
T32 · FY2020 · HL · contact PI
Project 3: Contribution of Small Airways to Cystic Fibrosis Lung Disease Pathogenesis$356,949
P01 · FY2020 · HL · contact PI
In Vitro Models and Cell Culture Core$185,400
P01 · FY2020 · HL · contact PI
Cells and Tissue Core-Core 5$156,510
P30 · FY2020 · DK · contact PI
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis$1,055,623
R01 · FY2019 · HL
Multidisciplinary Lung Research Career Development Program$1,035,792
T32 · FY2019 · HL · contact PI
Project 3: Contribution of Small Airways to Cystic Fibrosis Lung Disease Pathogenesis$356,949
P01 · FY2019 · HL · contact PI
Core C: In Vitro Models and Cell Culture$183,000
P01 · FY2019 · HL · contact PI
Cells and Tissue Core$166,254
P30 · FY2019 · DK · contact PI
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis$1,056,522
R01 · FY2018 · HL
Project 3: Contribution of Small Airways to Cystic Fibrosis Lung Disease Pathogenesis$356,949
P01 · FY2018 · HL · contact PI
Core C: In Vitro Models and Cell Culture$183,000
P01 · FY2018 · HL · contact PI
Cells and Tissue Core$167,707
P30 · FY2018 · DK · contact PI
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis$1,070,303
R01 · FY2017 · HL
Airway pH and antimocrobial activity in early cystic fibrosis$347,300
P01 · FY2017 · HL · contact PI
Core C: In Vitro Models and Cell Culture$183,000
P01 · FY2017 · HL · contact PI
Cells and Tissue Core$168,185
P30 · FY2017 · DK · contact PI
In Vitro Models and Cell Culture Core$75,500
P01 · FY2017 · HL · contact PI
Airway pH and antimocrobial activity in early cystic fibrosis$347,300
P01 · FY2016 · HL · contact PI
Core C: In Vitro Models and Cell Culture$182,550
P01 · FY2016 · HL · contact PI
Cells and Tissue Core$167,652
P30 · FY2016 · DK · contact PI
In Vitro Models and Cell Culture Core$75,500
P01 · FY2016 · HL · contact PI
Airway pH and antimocrobial activity in early cystic fibrosis$342,996
P01 · FY2015 · HL · contact PI
Core C: In Vitro Models and Cell Culture$181,200
P01 · FY2015 · HL · contact PI
Cells and Tissue Core$166,100
P30 · FY2015 · DK · contact PI
In Vitro Models and Cell Culture Core$71,197
P01 · FY2015 · HL · contact PI
Airway pH and antimocrobial activity in early cystic fibrosis$341,549
P01 · FY2014 · HL · contact PI
Cells and Tissue Core$159,302
P30 · FY2014 · DK · contact PI
In Vitro Models and Cell Culture Core$69,751
P01 · FY2014 · HL · contact PI
Airway pH and antimocrobial activity in early cystic fibrosis$330,630
P01 · FY2013 · HL · contact PI
Directed evolutioni of AAV for gene theraphy in a pig model of cystic fibrosis$269,975
P01 · FY2013 · HL · contact PI
Cell Culture Core$269,974
P01 · FY2013 · HL · contact PI
Cells and Tissue Core$154,605
P30 · FY2013 · DK · contact PI
In Vitro Models and Cell Culture Core$71,874
P01 · FY2013 · HL · contact PI
Ancillary Study 1$2,044,958
U01 · FY2012 · HL · contact PI
Early airway infection in a porcne model of cystic fibrosis$288,090
P01 · FY2012 · HL · contact PI
Cell Culture Core$283,562
P01 · FY2012 · HL · contact PI
Directed evolutioni of AAV for gene theraphy in a pig model of cystic fibrosis$283,561
P01 · FY2012 · HL · contact PI
Cells and Tissue Core$168,880
P30 · FY2012 · DK · contact PI
in Vitro Models and Cell Culture Core$75,062
P01 · FY2012 · HL · contact PI
Ancillary Study 1$2,076,535
U01 · FY2011 · HL · contact PI
Early airway infection in a porcne model of cystic fibrosis$288,090
P01 · FY2011 · HL · contact PI
Cell Culture Core$282,821
P01 · FY2011 · HL · contact PI
Directed evolutioni of AAV for gene theraphy in a pig model of cystic fibrosis$282,820
P01 · FY2011 · HL · contact PI
in Vitro Models and Cell Culture Core$75,062
P01 · FY2011 · HL · contact PI
Ancillary Study 1$1,205,390
U01 · FY2010 · HL · contact PI
Early airway infection in a porcne model of cystic fibrosis$288,090
P01 · FY2010 · HL · contact PI
Cell Culture Core$283,278
P01 · FY2010 · HL · contact PI
Directed evolutioni of AAV for gene theraphy in a pig model of cystic fibrosis$283,278
P01 · FY2010 · HL · contact PI
in Vitro Models and Cell Culture Core$75,059
P01 · FY2010 · HL · contact PI
Request for Funds to Purchase a Replacement Laser Scanning Confocal Microscope$500,000
S10 · FY2009 · RR · contact PI
Cell Culture Core$288,612
P01 · FY2009 · HL · contact PI
Directed evolutioni of AAV for gene theraphy in a pig model of cystic fibrosis$288,612
P01 · FY2009 · HL · contact PI
Early airway infection in a porcne model of cystic fibrosis$288,090
P01 · FY2009 · HL · contact PI
Cells and Tissue Core$168,833
P30 · FY2009 · DK · contact PI
in Vitro Models and Cell Culture Core$75,062
P01 · FY2009 · HL · contact PI
Interactions of AAV5 with Sialic Acid and PDGF Receptors$333,915
P01 · FY2008 · HL · contact PI
Early airway infection in a porcne model of cystic fibrosis$288,090
P01 · FY2008 · HL · contact PI
Core-- Administration$120,620
P01 · FY2008 · HL · contact PI
in Vitro Models and Cell Culture Core$75,062
P01 · FY2008 · HL · contact PI
Xylitol Enhancement of Bacterial Killing by Airway$430,308
P50 · FY2007 · HL · contact PI
Interactions of AAV5 with Sialic Acid and PDGF Receptors$330,839
P01 · FY2007 · HL · contact PI
Ligand-Receptor Segregation and Airway Remodeling$314,678
R01 · FY2007 · HL · contact PI
Core-- Administration$119,725
P01 · FY2007 · HL · contact PI
Ligand-Receptor Segregation and Airway Remodeling$324,077
R01 · FY2006 · HL · contact PI
Xylitol Enhancement of Bacterial Killing by Airway$268,740
P50 · FY2006 · HL · contact PI
Interactions of AAV5 with Sialic Acid and PDGF Receptors$206,916
P01 · FY2006 · HL · contact PI
Core-- Administration$74,997
P01 · FY2006 · HL · contact PI
SAFETY OF AEROSOLIZED XYLITOL IN SUBJECTS WITH CYSTIC FIBROSIS$2,316
M01 · FY2006 · RR · contact PI
Ligand-Receptor Segregation and Airway Remodeling$331,875
R01 · FY2005 · HL
Xylitol Enhancement of Bacterial Killing by Airway$261,412
P50 · FY2005 · HL
Interactions of AAV5 with Sialic Acid and PDGF Receptors$200,891
P01 · FY2005 · HL
Core-- Administration$72,937
P01 · FY2005 · HL
BRONCHOSCOPIC ASSESSMENT OF AIRWAY RETENTION TIME OF AEROSOLIZED XYLITOL$5,180
M01 · FY2005 · RR
Ligand-Receptor Segregation and Airway Remodeling$331,875
R01 · FY2004 · HL
Xylitol Enhancement of Bacterial Killing by Airway$253,313
P50 · FY2004 · HL
Interactions of AAV5 with Sialic Acid and PDGF Receptors$195,025
P01 · FY2004 · HL
Core-- Administration$72,541
P01 · FY2004 · HL
Effect of Ionic Versus Non-Ionic Osmolytes in the Airway$3,373
M01 · FY2004 · RR
Bronchoscopic Assessment of Airway Retention Time$1,012
M01 · FY2004 · RR
Xylitol Enhancement of Bacterial Killing by Airway$231,687
P50 · FY2003 · HL
CORE--CELLS AND TISSUES$296,752
P30 · FY2002 · DK
IMPROVED EFFICACY OF ADENOVIRUS MEDIATED GENE TRANSFER TO AIRWAY EPITHELIA$290,033
P01 · FY2002 · HL
ELECTROLYTE COMPOSITION OF SURFACE FLUID IN NORMAL AND CF AIRWAY EPITHELIA$243,516
P50 · FY2002 · HL
CORE--CELLS AND TISSUES$296,752
P30 · FY2001 · DK
IMPROVED EFFICACY OF ADENOVIRUS MEDIATED GENE TRANSFER TO AIRWAY EPITHELIA$290,033
P01 · FY2001 · HL
ELECTROLYTE COMPOSITION OF SURFACE FLUID IN NORMAL AND CF AIRWAY EPITHELIA$243,516
P50 · FY2001 · HL
ELECTROLYTE COMPOSITION OF SURFACE FLUID IN NORMAL AND CF AIRWAY EPITHELIA$293,069
P50 · FY2000 · HL
IMPROVED EFFICACY OF ADENOVIRUS MEDIATED GENE TRANSFER TO AIRWAY EPITHELIA$272,462
P01 · FY2000 · HL
CORE--CELLS AND TISSUES$143,268
P30 · FY2000 · DK